These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10609670)

  • 1. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease.
    Bretsky PM; Buckwalter JG; Seeman TE; Miller CA; Poirier J; Schellenberg GD; Finch CE; Henderson VW
    Alzheimer Dis Assoc Disord; 1999; 13(4):216-21. PubMed ID: 10609670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
    Drigalenko E; Poduslo S; Elston R
    Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
    Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
    Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.
    Neu SC; Pa J; Kukull W; Beekly D; Kuzma A; Gangadharan P; Wang LS; Romero K; Arneric SP; Redolfi A; Orlandi D; Frisoni GB; Au R; Devine S; Auerbach S; Espinosa A; Boada M; Ruiz A; Johnson SC; Koscik R; Wang JJ; Hsu WC; Chen YL; Toga AW
    JAMA Neurol; 2017 Oct; 74(10):1178-1189. PubMed ID: 28846757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender effect on apolipoprotein E epsilon4 allele-associated risk for sporadic Alzheimer's disease.
    Combarros O; Leno C; Oterino A; Berciano J; Fernández-Luna JL; Fernández-Viadero C; Peña N; Miró J; Delgado M
    Acta Neurol Scand; 1998 Jan; 97(1):68-71. PubMed ID: 9482681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
    Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
    Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotypes associated with Alzheimer disease and concomitant stroke.
    Fekih-Mrissa N; Klai S; Mrad M; Mansour M; Zaouali J; Gritli N; Mrissa R
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):681-5. PubMed ID: 23871727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: findings from the Maracaibo Aging Study.
    Molero AE; Pino-Ramírez G; Maestre GE
    Neurosci Lett; 2001 Jul; 307(1):5-8. PubMed ID: 11516561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.
    Hackenhaar FS; Josefsson M; Adolfsson AN; Landfors M; Kauppi K; Hultdin M; Adolfsson R; Degerman S; Pudas S
    Alzheimers Res Ther; 2021 Jul; 13(1):130. PubMed ID: 34266503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
    Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
    Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.
    Tang MX; Stern Y; Marder K; Bell K; Gurland B; Lantigua R; Andrews H; Feng L; Tycko B; Mayeux R
    JAMA; 1998 Mar; 279(10):751-5. PubMed ID: 9508150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
    Wang PN; Liu HC; Liu TY; Chu A; Hong CJ; Lin KN; Chi CW
    Dement Geriatr Cogn Disord; 2005; 19(2-3):120-5. PubMed ID: 15591802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.